16 September 2016 - Since the announcement of the FDA Oncology Center of Excellence in June 2016 as part of the White House’s Cancer Moonshot, the FDA has been working to further the agency's efforts to get new oncology products into the hands of patients.

At the core of the Oncology Center of Excellence's (OCE's) work – and of the Cancer Moonshot – is taking a new look at what the FDA has been doing in the past so it can operate more efficiently in the future. The OCE will leverage the combined skills of oncologists and scientists with expertise in drugs, biologics, and devices to employ the best and most innovative approaches to bring forth safe new oncology products.

Read FDA blog